Janney Montgomery Scott LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Janney Montgomery Scott LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	BUY	$10.74 - $19.7 $89,861 - $164,829	8,367 Added 37.8%	30,500 $379,000
Q3 2018 Nov 05, 2018	SELL	$14.0 - $20.3 $42,938 - $62,260	-3,067 Reduced 12.17%	22,133 $424,000
Q2 2018 Jul 24, 2018	BUY	$6.37 - $14.02 $35,990 - $79,213	5,650 Added 28.9%	25,200 $343,000
Q1 2018 Apr 19, 2018	BUY	$3.72 - $7.64 $72,726 - $149,362	19,550 New	19,550 $141,000

294

90.5M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.